New study may shed light on how parasite strain diversity can impact Chagas disease progression

New research from Tulane University may shed light on how parasite strain diversity can impact Chagas disease progression and severity.

Diabetes remains fastest-growing medtech market despite ‘some risk’ from new drugs: analysts

Dive Brief: New diabetes medicines could apply “short-lived pressures” to medtech companies by affecting the use of insulin, according to analysts at Mizuho. The development

June 30, 2023

SSRIs and SNRIs Weaken Psilocybin’s Effects, New Study Finds

As psilocybin gains prominence in treating affective disorders like treatment-resistant depression and major depressive disorder, and advanced clinical trials aim to prove that the active

July 20, 2023

$11 million NIH grant focuses on cognitive function in Down syndrome-associated Alzheimer’s

Neurologist Beau Ances, MD, PhD, talks with his patient, Adam Kloppenberg, who has Down syndrome, at Washington University School of Medicine in St. Louis. People

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.